J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Gen Virol 67 (1986), 899-905; DOI 10.1099/0022-1317-67-5-899
© 1986 Society for General Microbiology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Magrath, D. I.
Right arrow Articles by Hovi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Magrath, D. I.
Right arrow Articles by Hovi, T.
Agricola
Right arrow Articles by Magrath, D. I.
Right arrow Articles by Hovi, T.

Antigenic and Molecular Properties of Type 3 Poliovirus Responsible for an Outbreak of Poliomyelitis in a Vaccinated Population

D. I. Magrath1, D. M. A. Evans1, M. Ferguson1, G. C. Schild1, P. D. Minor1, F. Horaud2, R. Crainic2, M. Stenvik3 and T. Hovi3

1 National Institute for Biological Standards and Control, Holly Hill, Hampstead, London NW3 6RB, U.K.
2 Institut Pasteur, 25 rue du Dr Roux, Paris 75724, France
and3 National Public Health Institute, Mannerheimintie 166, Helsinki, Finland

Virus isolated from an outbreak of poliomyelitis in Finland has been examined serologically and at the molecular level. The causative agent was an antigenically unusual strain of type 3 poliovirus, which was unrelated to the strains used to manufacture either live or killed poliovaccines. It is likely that the antigenic properties of the virus played a part in establishing a limited outbreak of poliomyelitis in a vaccinated population.

Keywords: poliovirus, vaccinated population, antigenic variation

Received 9 January 1986; accepted 24 January 1986.


This article has been cited by other articles:


Home page
 CVIHome page
T. Herremans, J. H. J. Reimerink, T. G. Kimman, H. G. A. M. van der Avoort, and M. P. G. Koopmans
Antibody Responses to Antigenic Sites 1 and 3 of Serotype 3 Poliovirus after Vaccination with Oral Live Attenuated or Inactivated Poliovirus Vaccine and after Natural Exposure
Clin. Vaccine Immunol., January 1, 2000; 7(1): 40 - 44.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1986 by the Society for General Microbiology.